International Cannabis Weekly: 409

CANNABIS TELEMEDICINE INDUSTRY UNDER PRESSURE FROM GERMAN & AUSTRALIAN REGULATORS

The cannabis telemedicine industry, namely the flood of online healthcare businesses offering prescriptions virtually across global medical cannabis markets, has provided the greatest boom to the industry since the ‘green rush’ of 2018 in recent years.

READ MORE  »

FINAL NAIL IN THE COFFIN OF CANNABIS RESCHEDULING AS BUDGET BILL BLOCKS REFORM

READ MORE »

TURKEY HAS OFFICIALLY LAUNCHED ITS MEDICINAL CANNABIS PROGRAMME

READ MORE »

• German health minister has proposed a stricter access to medical cannabis in the country.
• Analysis: Why Europe’s medical cannabis sector keeps looking to Germany and its industry.
• How British firm Releaf is tackling prescriber recruitment and retention challenges.
• EU lawmakers are currently calling for 0.5% THC cap to protect the hemp industry.
• Grow Group’s acquisition of Avida has marked a significant and major UK milestone.
• UK cannabis company Celadon is now set to delist from AIM amid wider exit trend.
• Avida deal signals UK cannabis distribution transformation by Grow Group.
• BrewDog co-founder plans to invest £20m into his new medical cannabis company, Waterside Pharmaceuticals.

FREE DOWNLOAD »

• Glass House Brands has been raided by ICE, sparking a huge industry backlash response.
• New THC-CBD trial is currently exploring easing dementia-related agitation at end of life.
• Bipartisan push has reignited cannabis legalisation efforts in the state of Pennsylvania.
• The state of New Jersey approves first cannabis consumption lounges in state history.
• Houses in legal cannabis states are worth more and grow in value faster, new study finds. 
• Nebraska’s Omaha Tribe has adopted the cannabis regulatory code for first time ever.
• Kentucky is currently observing the arrival of its first ever medical cannabis inventory.
• Report finds that the US cannabis market has crashed from $37bn to just $4bn in three years.

• Canadian cannabis growers have made the move to shift their focus from grain to CBD flowers.
• Canadian cannabis firm Aurora has earned EU GMP status for its dedicated distribution centre.
• HYTN has announced it has won a cannabis drug licence for prescription cannabinoid medicines.
• Pure Sunfarms has recently published new findings on cannabis potency variation.
• Canadian military veterans account for over $1 billion in medical cannabis registrations.
• THC levels are varying quite significantly in dried flower, a new Canadian study finds.

• Dominica is currently taking steps to regulate and develop medical cannabis framework.
• Uruguay is reflecting on a decade of legalisation in a brand-new 10-year report.
• Brazilian company Blis Pharma has gained traction in medical cannabis development.
• Argentina’s ANMAT bans certain cannabis oils and injectable beauty product.

• A fully legalised cannabis market could add $10bn to Victoria’s economy, according to reports.
• Australia’s medical bodies are now reviewing doctor regulation on cannabis prescribing.
• Thailand has started restricting cannabis use to medical purposes, hitting local growers.
• New Zealand cannabis firms are starting to look towards Europe for export partnerships.

• Israeli pharma-tech company Syqe Medical has laid off 50 of its 154 employees in Tel Aviv. 
• Lebanon is currently eyeing economic recovery through a regulated cannabis industry.
• IM Cannabis has submitted a new foreign issuer report with regulators from the USA.
• Agri-tech is in the process of turbo-charging South Africa’s cannabis production boom.